erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
scottish widows demands auto-enrolment threshold is scrapped
.ai-based software may help predict risk of dementia
.
.
.
.